BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11160862)

  • 1. Rapid polyubiquitination and proteasomal degradation of a mutant form of NAD(P)H:quinone oxidoreductase 1.
    Siegel D; Anwar A; Winski SL; Kepa JK; Zolman KL; Ross D
    Mol Pharmacol; 2001 Feb; 59(2):263-8. PubMed ID: 11160862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1.
    Asher G; Lotem J; Sachs L; Kahana C; Shaul Y
    Proc Natl Acad Sci U S A; 2002 Oct; 99(20):13125-30. PubMed ID: 12232053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of the molecular chaperone Hsp70 with human NAD(P)H:quinone oxidoreductase 1.
    Anwar A; Siegel D; Kepa JK; Ross D
    J Biol Chem; 2002 Apr; 277(16):14060-7. PubMed ID: 11821413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of murine NAD(P)H:quinone oxidoreductase by 2,3,7,8-tetrachlorodibenzo-p-dioxin requires the CNC (cap 'n' collar) basic leucine zipper transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2): cross-interaction between AhR (aryl hydrocarbon receptor) and Nrf2 signal transduction.
    Ma Q; Kinneer K; Bi Y; Chan JY; Kan YW
    Biochem J; 2004 Jan; 377(Pt 1):205-13. PubMed ID: 14510636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P53 hot-spot mutants are resistant to ubiquitin-independent degradation by increased binding to NAD(P)H:quinone oxidoreductase 1.
    Asher G; Lotem J; Tsvetkov P; Reiss V; Sachs L; Shaul Y
    Proc Natl Acad Sci U S A; 2003 Dec; 100(25):15065-70. PubMed ID: 14634213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytosolic components are required for proteasomal degradation of newly synthesized apolipoprotein B in permeabilized HepG2 cells.
    Sakata N; Stoops JD; Dixon JL
    J Biol Chem; 1999 Jun; 274(24):17068-74. PubMed ID: 10358059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase).
    Traver RD; Siegel D; Beall HD; Phillips RM; Gibson NW; Franklin WA; Ross D
    Br J Cancer; 1997; 75(1):69-75. PubMed ID: 9000600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced proteasomal degradation of mutant human thiopurine S-methyltransferase (TPMT) in mammalian cells: mechanism for TPMT protein deficiency inherited by TPMT*2, TPMT*3A, TPMT*3B or TPMT*3C.
    Tai HL; Fessing MY; Bonten EJ; Yanishevsky Y; d'Azzo A; Krynetski EY; Evans WE
    Pharmacogenetics; 1999 Oct; 9(5):641-50. PubMed ID: 10591545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NRH:quinone oxidoreductase 2 and NAD(P)H:quinone oxidoreductase 1 protect tumor suppressor p53 against 20s proteasomal degradation leading to stabilization and activation of p53.
    Gong X; Kole L; Iskander K; Jaiswal AK
    Cancer Res; 2007 Jun; 67(11):5380-8. PubMed ID: 17545619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination.
    Sheaff RJ; Singer JD; Swanger J; Smitherman M; Roberts JM; Clurman BE
    Mol Cell; 2000 Feb; 5(2):403-10. PubMed ID: 10882081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of ubiquitin in proteasomal degradation of mutant alpha(1)-antitrypsin Z in the endoplasmic reticulum.
    Teckman JH; Gilmore R; Perlmutter DH
    Am J Physiol Gastrointest Liver Physiol; 2000 Jan; 278(1):G39-48. PubMed ID: 10644560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Degradation of the epstein-barr virus latent membrane protein 1 (LMP1) by the ubiquitin-proteasome pathway. Targeting via ubiquitination of the N-terminal residue.
    Aviel S; Winberg G; Massucci M; Ciechanover A
    J Biol Chem; 2000 Aug; 275(31):23491-9. PubMed ID: 10807912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitin/proteasome pathway regulates levels of retinoic acid receptor gamma and retinoid X receptor alpha in human keratinocytes.
    Boudjelal M; Wang Z; Voorhees JJ; Fisher GJ
    Cancer Res; 2000 Apr; 60(8):2247-52. PubMed ID: 10786691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NAD(P)H:quinone oxidoreductase 1 and nrh:quinone oxidoreductase 2 activity and expression in bladder and ovarian cancer and lower NRH:quinone oxidoreductase 2 activity associated with an NQO2 exon 3 single-nucleotide polymorphism.
    Jamieson D; Wilson K; Pridgeon S; Margetts JP; Edmondson RJ; Leung HY; Knox R; Boddy AV
    Clin Cancer Res; 2007 Mar; 13(5):1584-90. PubMed ID: 17332305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'ER degradation' of a mutant yeast plasma membrane protein by the ubiquitin-proteasome pathway.
    Galan JM; Cantegrit B; Garnier C; Namy O; Haguenauer-Tsapis R
    FASEB J; 1998 Mar; 12(3):315-23. PubMed ID: 9506475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteasome-dependent degradation of the human estrogen receptor.
    Nawaz Z; Lonard DM; Dennis AP; Smith CL; O'Malley BW
    Proc Natl Acad Sci U S A; 1999 Mar; 96(5):1858-62. PubMed ID: 10051559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyamine analogues inhibit the ubiquitination of spermidine/spermine N1-acetyltransferase and prevent its targeting to the proteasome for degradation.
    Coleman CS; Pegg AE
    Biochem J; 2001 Aug; 358(Pt 1):137-45. PubMed ID: 11485561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerated ubiquitination and proteasome degradation of a genetic variant of inducible nitric oxide synthase.
    Ying WZ; Sanders PW
    Biochem J; 2003 Dec; 376(Pt 3):789-94. PubMed ID: 12959638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The stabilization mechanism of mutant-type p53 by impaired ubiquitination: the loss of wild-type p53 function and the hsp90 association.
    Nagata Y; Anan T; Yoshida T; Mizukami T; Taya Y; Fujiwara T; Kato H; Saya H; Nakao M
    Oncogene; 1999 Oct; 18(44):6037-49. PubMed ID: 10557093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An ATP-stabilized inhibitor of the proteasome is a component of the 1500-kDa ubiquitin conjugate-degrading complex.
    Driscoll J; Frydman J; Goldberg AL
    Proc Natl Acad Sci U S A; 1992 Jun; 89(11):4986-90. PubMed ID: 1317579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.